Song Xu
- Cancer Research top 5%
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 5
- Cancer, Lipids, and Metabolism 5
- Rehabilitation top 5%
- Magnolia and Illicium research 10
- Rheumatology top 5%
- Molecular Biology top 10%
- Natural product bioactivities and synthesis 8
- Plant-derived Lignans Synthesis and Bioactivity 7
- Circular RNAs in diseases 5
-
- Inflammatory mediators and NSAID effects 6
In The Last Decade
Song Xu
48 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 353
- Rehabilitation 149
- Rheumatology 261
- Orthopedics and Sports Medicine 110
- Molecular Biology 840
Countries citing papers authored by Song Xu
This map shows the geographic impact of Song Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Song Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Song Xu more than expected).
Fields of papers citing papers by Song Xu
This network shows the impact of papers produced by Song Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Song Xu. The network helps show where Song Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Song Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2020 | 7 | |
| 5 | 2020 | 8 | |
| 6 | Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2breakdown → | 2018 | 349 |
| 7 | 2017 | 51 | |
| 8 | 2015 | 51 | |
| 9 | 2015 | 11 | |
| 10 | 2015 | 45 | |
| 11 | 2015 | 22 | |
| 12 | 2015 | 12 | |
| 13 | 2014 | 29 | |
| 14 | 2013 | 27 | |
| 15 | 2012 | 24 | |
| 16 | 2012 | 58 | |
| 17 | 2012 | 13 | |
| 18 | 2012 | 14 | |
| 19 | 2011 | 12 | |
| 20 | 2008 | 42 |
About Song Xu
Song Xu is a scholar working on Rehabilitation, Cancer Research and Pharmacology, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include Magnolia and Illicium research (10 papers), Natural product bioactivities and synthesis (8 papers), Plant-derived Lignans Synthesis and Bioactivity (7 papers), MicroRNA in disease regulation (6 papers), Inflammatory mediators and NSAID effects (6 papers), Cancer-related molecular mechanisms research (5 papers), Cancer, Lipids, and Metabolism (5 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (353 citations), Rehabilitation (149 citations) and Rheumatology (261 citations). Song Xu has collaborated with scholars based in China, Japan and Australia. Frequent co-authors include Xiaochun Bai, Jingping Ge, Wenquan Zhou, Xiaoming Yi, Chuangxin Lin, Daozhang Cai, Shuang‐Gang Ma, Denghui Xie, Chun Zeng and Zhenyu Wang. Their work appears in journals such as PLoS ONE, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.